Byannli (previously Paliperidone Janssen-Cilag International)

paliperidone palmitate

Centralised EU authorisationActive

Verified 2026-10-09 · EMA

Composition

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
US 17	Erzofri extended-release INJECTION · PALIPERIDONE PALMITATE 78 mg/.5mL 72526-106 Shandong Luye Pharmaceutical Co., Ltd. Erzofri extended-release INJECTION · PALIPERIDONE PALMITATE 39 mg/.25mL 72526-105 Shandong Luye Pharmaceutical Co., Ltd. Erzofri extended-release INJECTION · PALIPERIDONE PALMITATE 234 mg/1.5mL 72526-109 Shandong Luye Pharmaceutical Co., Ltd. Erzofri extended-release INJECTION · PALIPERIDONE PALMITATE 156 mg/mL 72526-108 Shandong Luye Pharmaceutical Co., Ltd. Erzofri extended-release INJECTION · PALIPERIDONE PALMITATE 117 mg/.75mL 72526-107 Shandong Luye Pharmaceutical Co., Ltd. All products in this country (17)

Country

Products

US 17

Erzofri extended-release
INJECTION · PALIPERIDONE PALMITATE 78 mg/.5mL
72526-106
Shandong Luye Pharmaceutical Co., Ltd.
Erzofri extended-release
INJECTION · PALIPERIDONE PALMITATE 39 mg/.25mL
72526-105
Shandong Luye Pharmaceutical Co., Ltd.
Erzofri extended-release
INJECTION · PALIPERIDONE PALMITATE 234 mg/1.5mL
72526-109
Shandong Luye Pharmaceutical Co., Ltd.
Erzofri extended-release
INJECTION · PALIPERIDONE PALMITATE 156 mg/mL
72526-108
Shandong Luye Pharmaceutical Co., Ltd.
Erzofri extended-release
INJECTION · PALIPERIDONE PALMITATE 117 mg/.75mL
72526-107
Shandong Luye Pharmaceutical Co., Ltd.

Import and control

United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b81-7ce2-a793-78d45b9c0ea2,01a1208c-6c63-7088-997d-f7e8798e4a97,01a1208f-09ad-759b-ba56-b52d3142edcf,01a12090-e33e-77fc-8f70-d0332ec054bc,01a12091-b7f6-7c51-bbe8-8d1650b1fd68;count=17 · valid from 2026-10-09 · verified 2026-10-09